The launch of new chemical company Lanxess onto the stock market is scheduled for January 31, 2005. The corresponding listing memorandum has been submitted to the Frankfurt Stock Exchange. Under current plans, the spin-off will be entered into the commercial register for Bayer AG on January 28. Trading of the company’s shares could then begin on Monday, January 31.

At the extraordinary stockholders’ meeting on November 17, the stockholders of Bayer AG voted by a broad majority of the share capital represented to place the new company on the stock market by way of a spin-off. Bayer stockholders will be granted one Lanxess share for every ten Bayer shares they hold at the close of business on the day on which the spin-off is entered into the commercial register for Bayer AG.